Paper Review Records
All Paper Review Records
18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
476
days
Years of Life Lost in Incidental Prostate Cancer
AuthorsFabian Falkenbach; Mattia Longoni; Andrea Marmiroli; Quynh Chi Le; Calogero Catanzaro; Michele Nicolazzini; Federico Polverino; Jordan A. Goyal; Riccardo Schiavina; Alessandro Volpe; Gennaro Musi; Felix K. H. Chun; Alberto Briganti; Francesco Montorsi; Fred Saad; Shahrokh F. Shariat; Lars Budäus; Markus Graefen; Pierre I. Karakiewicz
Affiliations1. Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montreal Health Center Montreal Quebec Canada; 2. Martini‐Klinik Prostate Cancer Center University Medical Center Hamburg‐Eppendorf Hamburg Germany; 3. Department of Urology University Hospital Heidelberg Heidelberg Germany; 4. Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute IRCCS San Raffaele Scientific Institute Milan Italy; 5. Vita‐Salute San Raffaele University Milan Italy; 6. Department of Urology IEO European Institute of Oncology, IRCCS Milan Italy; 7. Department of Oncology and Haemato‐Oncology Università degli Studi di Milano Milan Italy; 8. Department of Urology, Goethe University Frankfurt University Hospital Frankfurt am Main Germany; 9. Department of Urology University of Bologna, St. Orsola‐Malpighi Hospital Bologna Italy; 10. Department of Translational Medicine, Division of Urology, University of Eastern Piedmont Maggiore della Carità Hospita Novara Italy; 11. Department of Oncology, Division of Urology University of Turin Orbassano Italy; 12. Department of Neurosciences, Science of Reproduction and Odontostomatology University of Naples Federico II Naples Italy; 13. Department of Urology, Comprehensive Cancer Center Medical University of Vienna Vienna Austria; 14. Department of Urology Weill Cornell Medical College New York New York USA; 15. Department of Urology University of Texas Southwestern Medical Center Dallas Texas USA; 16. Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan; 17. Department of Urology University Medical Center Hamburg‐Eppendorf Hamburg Germany
49
days
Temporal Trends of Metastatic Prostate Cancer in the Prostate‐Specific Membrane Antigen Positron Emission Tomography Era in the United States
AuthorsLeonardo Quarta; Maximilian Filzmayer; Michele Petix; Filippo Orlandi; Jordan A. Goyal; Felix K. H. Chun; Matteo Ferro; Salvatore Micali; Shahrokh F. Shariat; Francesco Barletta; Armando Stabile; Giorgio Gandaglia; Francesco Montorsi; Fred Saad; Alberto Briganti; Pierre I. Karakiewicz
Affiliations1. Cancer Prognostics and Health Outcomes Unit University of Montréal Health Center, Division of Urology Montréal Québec Canada; 2. Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute IRCCS San Raffaele Scientific Institute Milan Italy; 3. Vita‐Salute San Raffaele University Milan Italy; 4. Department of Urology, University Hospital Goethe University Frankfurt Frankfurt am Main Germany; 5. Department of Urology ASST Santi Paolo e Carlo Milan Italy; 6. Università degli Studi di Milano Milan Italy; 7. Department of Urology, AOU di Modena University of Modena and Reggio Emilia Modena Italy; 8. Department of Urology, Comprehensive Cancer Center Medical University of Vienna Vienna Austria; 9. Department of Urology Weill Cornell Medical College New York New York USA; 10. Department of Urology University of Texas Southwestern Medical Center Dallas Texas USA; 11. Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan
55
days
The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC
AuthorsKohei Hashimoto; Kouji Izumi; Takashi Shima; Yuki Kato; Koji Mita; Takehiko Okamura; Shogo Inoue; Shuichi Tatarano; Nobumichi Tanaka; Noriyasu Kawai; Manabu Kamiyama; Ippei Chikazawa; Seiji Hoshi; Takashi Fukagai; Kazuyoshi Shigehara; Shizuko Takahara; Atsushi Mizokami
Affiliations1. Department of Urology, School of Medicine Sapporo Medical University Hokkaido Sapporo Japan; 2. Department of Integrative Cancer Therapy and Urology Kanazawa University Graduate School of Medical Science Ishikawa Kanazawa Japan; 3. Department of Urology Toyama Prefectural Central Hospital Toyama Japan; 4. Department of Urology Fukui‐ken Saiseikai Hospital Fukui Japan; 5. Department of Urology Hiroshima City North Medical Center Asa Citizens Hospital Hiroshima Asakita‐ku Japan; 6. Department of Urology Anjo Kosei Hospital Anjo Aichi Japan; 7. Department of Urology Kobatake Hospital Fukuyama Hiroshima Japan; 8. Department of Urology, Graduate School of Medical and Dental Sciences Kagoshima University Kagoshima Japan; 9. Department of Urology Nara Medical University Nara Kashihara Japan; 10. Department of Nephro‐urology Nagoya City University Graduate School of Medical Sciences Nagoya, Aichi Mizuho‐ku Japan; 11. Department of Urology Nagoya City University Midori Municipal Hospital Nagoya Midori‐ku Japan; 12. Department of Urology University of Yamanashi Graduate School of Medical Sciences Yamanashi Chuo Japan; 13. Department of Urology Kanazawa Medical University Ishikawa Kahoku Japan; 14. Department of Urology Fukushima Medical University School of Medicine Fukushima Japan; 15. Department of Urology Showa University School of Medicine Tokyo Shinagawa‐ku Japan; 16. Department of Urology Ishikawa Prefectural Central Hospital Ishikawa Kanazawa Japan; 17. Innovative Clinical Research Center Kanazawa University Ishikawa Kanazawa Japan; 18. Medical Research Support Center University of Fukui Hospital Fukui Japan
63
days
A Simple Cell Culture Assay for Human Prostatic Branching Morphogenesis Spotlights Bone Morphogenetic Protein Signaling as a Therapeutic Target in Benign Prostatic Hyperplasia
AuthorsAnna S. Pollack; James D. Brooks; Jonathan R. Pollack
Affiliations1. Department of Pathology Stanford University School of Medicine California Stanford USA; 2. Department of Urology Stanford University School of Medicine California Stanford USA
69
days
Salvage Androgen Deprivation Therapy Use After Definitive Radiotherapy With vs Without Androgen Deprivation Therapy in Prostate Cancer
AuthorsJiaye Shen; Aaron J. Katz; Yahui Xie; Ronald C. Chen; Mutlay Sayan
Affiliations1. Department of Radiation Oncology University of Kansas Medical Center Kansas City Kansas USA; 2. Department of Population Health University of Kansas Medical Center Kansas City Kansas USA; 3. Department of Radiation Oncology Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA
91
days
Association Between Intraoperative Prostate Bed Blood Flow and Postoperative Lower Urinary Tract Symptoms After Robot‐Assisted Radical Prostatectomy
AuthorsChikao Aoyagi; Shintaro Aso; Masahiro Tachibana; Naotaka Gunge; Takuya Miyahara; Seiya Yamashita; Riko Yokoyama; Keisuke Noda; Akito Iwata; Ryota Sako; Aiko Fujikawa; Kosuke Tominaga; Takeshi Miyazaki; Yu Okabe; Nobuyuki Nakamura; Masanori Nomiya; Nobuhiro Haga
Affiliations1. Department of Urology, Faculty of Medicine Fukuoka University Fukuoka Japan; 2. National Center for Geriatrics and Gerontology Aichi Japan
137
days
Clinical Variable‐Based Machine Learning for Predicting Early mCRPC Using Exclusively Clinical Variables: Development and Multicenter External Validation
AuthorsMiguel Ángel Gómez‐Luque; Pedro De Pablos‐Rodríguez; Daniel Adolfo Pérez‐Fentes; Natalia Picola‐Brau; Arnau Abella‐Serra; María Elena Martínez‐Corral; Paula Rodríguez‐Marcos; Alicia López‐Abad; Marc Costa‐Planells; Sara Martínez‐Breijo; Ana Díaz‐Pedrouzo; Francisco Javier Vera‐Ballesteros; Joaquin Abuín‐García; Celia Bardella‐Altarriba; Jose Francisco Suárez‐Novo; Ángel García Cortés; Pedro Ángel López‐González; Mireia García‐Puche; Jose Agustín López González; Rocío Martínez‐Corral
Affiliations1. Department of Urology Hospital Universitario Virgen del Rocio Seville Spain; 2. Foundation for Health Research Management in Seville (FISEVI) Seville Spain; 3. Department of Urology Instituto Valenciano de Oncología (IVO) Valencia Spain; 4. Urology Department Complejo Hospitalario Universitario de Santiago Santiago de Compostela Spain; 5. Department of Urology Hospital de Bellvitge Barcelona Spain; 6. Department of Urology Hospital Universitari Germans Trias i Pujol Barcelona Spain; 7. Department of Urology Hospital Virgen de la Arrixaca Murcia Spain; 8. Department of Urology Hospital Vall d'Hebrón Barcelona Spain; 9. Department of Urology Hospital Universitario A Coruña A Coruña Spain
173
days
Holmium Laser Enucleation of the Prostate (HoLEP) With Proactive Preservation of One Lateral Lobe: A Technique for Benign Prostatic Hyperplasia to Preserve Sexual Function
AuthorsYunwu Hao; Qianjun Liang; Bin Liu; Yao Jiang; Degang Chen
Affiliations1. Department of Urology Lu'an Hospital Affiliated of Anhui Medical University Lu'an Anhui China
104
days
Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity
AuthorsLeonardo Quarta; Michele Petix; Maximilian Filzmayer; Filippo Orlandi; Federico Polverino; Jordan A. Goyal; Matteo Ferro; Felix K. H. Chun; Salvatore Micali; Nicola Longo; Shahrokh F. Shariat; Francesco Barletta; Armando Stabile; Giorgio Gandaglia; Francesco Montorsi; Fred Saad; Alberto Briganti; Pierre I. Karakiewicz
Affiliations1. Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montréal Health Center Montréal Québec Canada; 2. Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute IRCCS San Raffaele Scientific Institute Milan Italy; 3. Vita‐Salute San Raffaele University Milan Italy; 4. Department of Urology ASST Santi Paolo e Carlo Milan Italy; 5. Università degli Studi di Milano Milan Italy; 6. Department of Urology, University Hospital Goethe University Frankfurt Frankfurt am Main Germany; 7. Department of Urology, AOU di Modena University of Modena and Reggio Emilia Modena Italy; 8. Department of Neurosciences, Science of Reproduction and Odontostomatology University of Naples Federico II Naples Italy; 9. Department of Urology, Comprehensive Cancer Center Medical University of Vienna Vienna Austria; 10. Department of Urology Weill Cornell Medical College New York New York USA; 11. Department of Urology University of Texas Southwestern Medical Center Dallas Texas USA; 12. Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan
46
days
Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI‐RADS 3 Lesions: A Two‐Center Retrospective Study
AuthorsAli Eroglu; Cem Tugrul Gezmis; Yusuf Arikan; Nusret Can Cilesiz; Omer Koras; Busra Emir; Mustafa Bahadir Can Balci; Mehmet Zeynel Keskin
Affiliations1. Department of Urology, University of Health Sciences İzmir Tepecik Training and Research Hospital İzmir Türkiye; 2. Department of Urology, University of Health Sciences İstanbul Taksim Training and Research Hospital İstanbul Türkiye; 3. Faculty of Medicine, Department of Biostatistics İzmir Katip Celebi University İzmir Türkiye
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days